U.S., Oct. 1 -- An application to own the trademark for 'ALCHEMAB' has been filed on Jul. 03, 2024.
Owner(s):
Alchemab Therapeutics Ltd; East Side Office 1.02, , UNITED KINGDOM
Goods and/or Services:
For: Pharmaceutical preparations incorporating antibodies for the treatment of neurological and neurodegenerative diseases and disorders, metabolic diseases and disorders, immunological diseases and disorders, oncological diseases and disorders, Amyotrophic Lateral Sclerosis (ALS), muscle atrophy, Parkinson's disease and Alzheimer's disease; pharmaceutical preparations incorporating antibody technology for the treatment of neurological and neurodegenerative diseases and disorders, metabolic diseases and disorders, immunological diseases and...